1455037-45-2 Usage
Uses
Used in Organic Synthesis:
(1s,3s)-3-fluoro-3-methylcyclobutanecarboxylic acid is used as a building block for the synthesis of various organic compounds. Its unique structure allows for the creation of new molecules with potential applications in different industries.
Used in Pharmaceutical Research:
(1s,3s)-3-fluoro-3-methylcyclobutanecarboxylic acid is used as a key intermediate in the development of new drugs. Its chiral nature and functional groups make it a promising candidate for the synthesis of pharmaceuticals with specific therapeutic effects.
Used in Material Science:
(1s,3s)-3-fluoro-3-methylcyclobutanecarboxylic acid is utilized in the development of new materials with unique properties. Its incorporation into polymers and other materials can lead to advancements in various fields, such as nanotechnology and materials engineering.
Check Digit Verification of cas no
The CAS Registry Mumber 1455037-45-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,5,5,0,3 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1455037-45:
(9*1)+(8*4)+(7*5)+(6*5)+(5*0)+(4*3)+(3*7)+(2*4)+(1*5)=152
152 % 10 = 2
So 1455037-45-2 is a valid CAS Registry Number.
1455037-45-2Relevant academic research and scientific papers
Synthesis and Physicochemical Properties of 3-Fluorocyclobutylamines
Chernykh, Anton V.,Radchenko, Dmytro S.,Chernykh, Alla V.,Kondratov, Ivan S.,Tolmachova, Nataliya A.,Datsenko, Olexandr P.,Kurkunov, Maxim A.,Zozulya, Sergey X.,Kheylik, Yuri P.,Bartels, Katharina,Daniliuc, Constantin G.,Haufe, Günter
, p. 6466 - 6471 (2015/10/19)
Hitherto unknown cis- and trans-3-alkyl- and 3-aryl-3-fluorocycobutylamines have been synthesised selectively from 3-oxocyclobutane carboxylic acid in six or seven steps. Comparison of their pKa and logD values with those of the fluorine-free p
RAF INHIBITOR COMPOUNDS
-
Page/Page column 80, (2013/09/26)
This invention provides compounds of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I); and use of a compound of Formula (I) for treating specified cancers.
